People In Brief

Von Eschenbach: Former FDA commissioner Andrew von Eschenbach will split his time between MD Anderson and the regulatory consulting firm Greenleaf Health LLC, which he will join as senior advisor. He returns to the University of Texas MD Anderson Cancer Center in Houston as an adjunct professor and will also serve on the advisory board of the David Koch Center for Applied Research in Genitourinary Cancers. On the policy side, von Eschenbach says he will use Greenleaf Health as a "launching pad" to participate in the discussion of macro health issues like personalized medicine, genomics and informatics. Von Eschenbach resigned as FDA commissioner upon the inauguration of President Obama; his successor has not yet been named